Literature DB >> 10648742

Acceptability and pain of outpatient hysteroscopy.

P De Iaco1, A Marabini, M Stefanetti, C Del Vecchio, L Bovicelli.   

Abstract

STUDY
OBJECTIVE: To investigate the pain and acceptability of diagnostic hysteroscopy performed without local anesthesia.
DESIGN: Prospective, observational study (Canadian Task Force classification II-2).
SETTING: University-associated department of obstetrics and gynecology. PATIENTS: The 1144 consecutive women who underwent diagnostic hysteroscopy.
INTERVENTIONS: Diagnostic hysteroscopy and endometrial biopsy as indicated.
MEASUREMENTS AND MAIN RESULTS: Patients were asked to rate the pain experienced on a 10-cm visual analog scale and to state if they were willing to repeat the procedure. The mean pain score was 4.7 +/- 2.5; 398 patients (34.8%) experienced severe pain. No risk factors for painful hysteroscopy were found, although abnormality of the cervical canal was associated with high pain scores. Acceptance of the procedure was high, 83.0% (950 women).
CONCLUSION: Diagnostic hysteroscopy is a painful procedure even when performed with atraumatic technique by experienced surgeons. Most women, however, stated they were willing to have a second procedure under the same conditions.

Entities:  

Mesh:

Year:  2000        PMID: 10648742     DOI: 10.1016/s1074-3804(00)80012-2

Source DB:  PubMed          Journal:  J Am Assoc Gynecol Laparosc        ISSN: 1074-3804


  12 in total

Review 1.  Pain relief for outpatient hysteroscopy.

Authors:  Gaity Ahmad; Sushant Saluja; Helena O'Flynn; Alessandra Sorrentino; Daniel Leach; Andrew Watson
Journal:  Cochrane Database Syst Rev       Date:  2017-10-05

2.  The potential role of endometrial nerve fibers in the pathogenesis of pain during endometrial biopsy at office hysteroscopy.

Authors:  Attilio Di Spiezio Sardo; Pasquale Florio; Loredana Maria Sosa Fernandez; Germano Guerra; Marialuigia Spinelli; Costantino Di Carlo; Marco Filippeschi; Carmine Nappi
Journal:  Reprod Sci       Date:  2014-05-07       Impact factor: 3.060

3.  Diagnostic hysteroscopy - a retrospective study of 1545 cases.

Authors:  Andreea Stefanescu; Bogdan Marinescu
Journal:  Maedica (Buchar)       Date:  2012-12

4.  The efficacy, cost and patient satisfaction of classic versus office hysteroscopy in cases with suspected intrauterine space occupying lesions with 3-dimension ultrasound and abnormal uterine bleeding.

Authors:  Tarık Filiz; Emek Doğer; Aydın Corakçı; Semih Ozeren; Eray Calışkan
Journal:  J Turk Ger Gynecol Assoc       Date:  2009-12-01

5.  Warm distension fluid reduces pain severity in office hysteroscopy: a randomized controlled trial.

Authors:  Selim Gulucu; Bulent Cakmak
Journal:  Ann Saudi Med       Date:  2021-06-01       Impact factor: 1.526

6.  Lidocaine-Prilocaine Cream as Analgesia for IUD Insertion: A Prospective, Randomized, Controlled, Triple Blinded Study.

Authors:  Samira Tavakolian; Mahbobeh Ahmadi Doulabi; Alireza Akbarzade Baghban; Alireza Mortazavi; Maryam Ghorbani
Journal:  Glob J Health Sci       Date:  2015-01-27

7.  Identification of global transcriptome abnormalities and potential biomarkers in eutopic endometria of women with endometriosis: A preliminary study.

Authors:  Luyang Zhao; Chenglei Gu; Mingxia Ye; Zhe Zhang; Weidong Han; Wensheng Fan; Yuanguang Meng
Journal:  Biomed Rep       Date:  2017-05-03

Review 8.  Management of abnormal uterine bleeding - focus on ambulatory hysteroscopy.

Authors:  Shilpa Kolhe
Journal:  Int J Womens Health       Date:  2018-03-22

9.  Use of video-based multimedia information to reduce anxiety before office hysteroscopy.

Authors:  Aysu Akca; Gulseren Yilmaz; Aytul Corbacioglu Esmer; Semra Yuksel; Nadiye Koroglu; Berna Aslan Cetin
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2019-10-28       Impact factor: 1.195

Review 10.  Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer.

Authors:  Kelechi Njoku; Davide Chiasserini; Eleanor R Jones; Chloe E Barr; Helena O'Flynn; Anthony D Whetton; Emma J Crosbie
Journal:  Front Oncol       Date:  2020-11-03       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.